MacroGenics





Ebit Cambiamento Data
AbbVie USD 5.81B 4.36B 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Biogen USD 659.6M 157M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Genmab DKK 432M 900.27M 2025-06
Geron USD -13.89M 1.43M 2025-09
Gilead Sciences USD 2.96B 551M 2025-12
J&J USD 5.11B 2.3B 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
MacroGenics USD 20.16M 55.51M 2025-09
Merck USD 6.24B 1.32B 2025-12
Pfizer USD 4.65B 71M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Xencor USD -47.52M 24.69M 2025-09


MacroGenics - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.